YY-20394
98%
blur_circular Chemical Specifications
description Product Description
YY-20394 is primarily investigated for its potential therapeutic applications in the field of oncology. It is being studied as a selective inhibitor of PI3Kδ, a key enzyme involved in the PI3K/AKT/mTOR signaling pathway, which plays a critical role in cell growth, survival, and metabolism. By targeting this pathway, YY-20394 shows promise in treating certain types of cancers, particularly hematologic malignancies like chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Its selective inhibition of PI3Kδ aims to minimize off-target effects, potentially offering a safer and more effective treatment option compared to broader PI3K inhibitors. Preclinical and clinical studies are ongoing to evaluate its efficacy, safety, and potential as a targeted cancer therapy.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| Appearance | Light yellow to yellow solid |
| Purity (%) | 97.5-100% |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
shopping_cart Available Sizes & Pricing
Cart
No products